4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780649-26-000002
CEO and Chairman sold 124,998 shares at $18.44 ($2,304,963)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form 10b5-1 | −124,998 | $18.44 | $2,304,963 | 2,459,245 | D |
| Open-market sales · 124,998 sh · avg $18.44 · $2,304,963 | ||||||
Loading xslF345X05/primary_doc.xml…